The Latest

• May 01, 2020

  By Charleston Lim

  Sinopharm Group's COVID-19 Inactivated Vaccine Approved For Clinical Trials

  The state-owned pharmaceutical company's second inactivated vaccine received clinical trial approval from regulators after showing promising results.

  

  The state-owned pharmaceutical company's second inactivated vaccine received clinical trial approval from regulators after showing promising results.